Evidence map›Paper›PMID 27009211›Full record

ArticleClinical and vaccine immunology : CVI2016

O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Amena Aktar, M Arifur Rahman, Sadia Afrin, M Omar Faruk, Taher Uddin, Aklima Akter, M Israk Nur Sami, Tahirah Yasmin, Fahima Chowdhury, Ashraful I Khan and 12 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Long-Term Kinetics of Serological Antibodies againstInternational journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Systemic, Mucosal, and Memory Immune Responses following Cholera.Tropical medicine and infectious disease · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Passive Immunity toPathogens & immunity · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Amena AktarInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
M Arifur RahmanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Sadia AfrinInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
M Omar FarukInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Taher UddinInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Aklima AkterInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
M Israk Nur SamiInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Tahirah YasminInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Fahima ChowdhuryInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Ashraful I KhanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Daniel T LeungDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Regina C LaRocqueDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Richelle C CharlesDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Taufiqur Rahman BhuiyanInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Anjali MandlikDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Meagan KellyDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pavol KováčNIDDK, LBC, National Institutes of Health, Bethesda, Maryland, USA.
Peng XuNIDDK, LBC, National Institutes of Health, Bethesda, Maryland, USA.
Stephen B CalderwoodDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jason B HarrisDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Edward T RyanDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA etryan@mgh.harvard.edu.
International Centre for Diarrhoeal Disease Research · BDHarvard University · USMassachusetts General Hospital · USNational Institutes of Health · US

Funding

Reactions And Immunochemistry Of CarbohydratesZIADK059701 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOVAC, PAVOL · 2009 to 2019
$9.5M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
Training program in vaccine development and public healthD43TW005572 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI QADRI, FIRDAUSI, RYAN, EDWARD T. · 2000 to 2025
$5.4M
O-Specific Polysaccharide Responses and CholeraR37AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Edward T. Ryan · 2020 to 2026
$5.1M
O-Specific Polysaccharide Responses and CholeraR01AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2018
$3.7M
Immune Responses to Vibrio Cholerae in ChildrenK08AI100923 · NIAID · UNIVERSITY OF UTAH · PI LEUNG, DANIEL TED · 2012 to 2016
$686k
High-throughput proteomic study of protective immunity in human cholera infectionK08AI089721 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHARLES, RICHELLE C · 2010 to 2014
$684k
Mucosal immune response to oral cholera vaccine Peru 15R03AI063079 · NIAID · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI QADRI, FIRDAUSI · 2005 to 2007
$158k
FIC NIH HHS D43 TW005572NIAID NIH HHS K08 AI089721NIAID NIH HHS K08 AI100923NIAID NIH HHS R01 AI106878NIAID NIH HHS R03 AI063079NIAID NIH HHS R37 AI106878NIAID NIH HHS U01 AI058935
6 · The paper itself

Abstract

Cholera caused by Vibrio cholerae O1 confers at least 3 to 10 years of protection against subsequent disease regardless of age, despite a relatively rapid fall in antibody levels in peripheral blood, suggesting that memory B cell responses may play an important role in protection. The V. cholerae O1-specific polysaccharide (OSP) component of lipopolysaccharide (LPS) is responsible for serogroup specificity, and it is unclear if young children are capable of developing memory B cell responses against OSP, a T cell-independent antigen, following cholera. To address this, we assessed OSP-specific memory B cell responses in young children (2 to 5 years, n = 11), older children (6 to 17 years, n = 21), and adults (18 to 55 years, n = 28) with cholera caused by V. cholerae O1 in Dhaka, Bangladesh. We also assessed memory B cell responses against LPS and vibriocidal responses, and plasma antibody responses against OSP, LPS, and cholera toxin B subunit (CtxB; a T cell-dependent antigen) on days 2 and 7, as well as days 30, 90, and 180 after convalescence. In all age cohorts, vibriocidal responses and plasma OSP, LPS, and CtxB-specific responses peaked on day 7 and fell toward baseline over the follow-up period. In comparison, we were able to detect OSP memory B cell responses in all age cohorts of patients with detectable responses over baseline for 90 to 180 days. Our results suggest that OSP-specific memory B cell responses can occur following cholera, even in the youngest children, and may explain in part the age-independent induction of long-term immunity following naturally acquired disease.

Indexed as

Immunologic MemoryAdolescentAdultAntibodies, BacterialBangladeshB-LymphocytesChildChild, PreschoolCholeraCholera ToxinFemaleHumansImmunoglobulin AImmunoglobulin MLipopolysaccharidesMaleAntibodies, BacterialCholera ToxinImmunoglobulin AImmunoglobulin MLipopolysaccharidesO Antigens

Identifiers

PMID27009211
PMCPMC4860469
OpenAlexW2307019207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.